And yet again ... price-sensitive-not-price-sensitive
ASX Announcement
$BIO looking to tap the QLD-based, government funded Australia's Food and Beverage Accelerator to support the development of its recently acquired proprietary probiotic strain.
$BIO already use Australian universities to lead other clinical research programs, so this is simply a smart way of tapping a pot of innovation funds, and tapping Australia's extensive research infrastructure.
Product development on the smell of an oily rag. I like it. But again, it shouldn't be a price sensitive announcement. It is simply BAU. IMHO. We'll see if the market agrees or not.
Disc: Held in RL and SM